Massive german cancer registry aims to uncover best treatments for kidney and bladder cancer

NCT ID NCT03374267

Recruiting now Knowledge-focused Sponsor: iOMEDICO AG Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 15, 2026 · Updated 3 times

Summary

This study is a large registry that will follow nearly 2,000 people with advanced kidney or bladder cancer in Germany. Researchers will collect information on the treatments patients actually receive, how well they work, and patients' quality of life. The goal is to understand real-world care and improve future treatment strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could reveal which treatments work best in real-world settings, helping doctors make more informed decisions for future patients.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly benefit participants. Results depend on data quality and may not apply outside Germany.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH-RISK MUSCLE INVASIVE UROTHELIAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infiltrating bladder urothelial carcinoma renal cell carcinoma transitional cell carcinoma urothelial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RENAL CELL CARCINOMA UROTHELIAL CARCINOMA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Multiple sites, Germany
RECRUITING

Multiple Locations, Germany

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.